Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...
With the presence of local authorities and partners from Vietnam, Thailand, and South Korea, Biogé...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
Biogen's activities from January to June 2024 reflect a period of strategic initiatives, clinical advancements, and or...
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to po...
Biogen Japan and Eisai have announced the termination of the co-promotion agreement that has been in place since January...
Australian industrial biotechnology leader MicroBioGen has offciated its state-of-the-art laboratories in Macquarie...
Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...
South Korea-based Samsung Biologics has reached an agreement with Biogen for the buyout of Biogen's stake in the Sa...
ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...
